过去一年中添加的文章，按日期排序
Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax in a Pregnant Woman
A Sakher, K Mora Massad… - B53. CASE REPORTS IN …, 2024 - atsjournals.org
54 天前 - … tuberous sclerosis or be sporadic due to loss of function mutations of TSC2. First line
therapy is with Sirolimus… with Tuberous Sclerosis Complex, or renal angiomyolipomas and …
therapy is with Sirolimus… with Tuberous Sclerosis Complex, or renal angiomyolipomas and …
An Unusual Case of Sporadic Lymphangioleiomyomatosis (S-LAM) in an Elderly Female
F Laxmidhar, K Lakhatariya, A Gupta… - B53. CASE REPORTS …, 2024 - atsjournals.org
54 天前 - … -walled cysts in lungs and angiomyolipomas in kidneys. … tuberous sclerosis (TSC-LAM)but
also as sporadic LAM (S… Sirolimus,the only drug approved for the treatment of LAM by …
also as sporadic LAM (S… Sirolimus,the only drug approved for the treatment of LAM by …
[HTML][HTML] Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit
J Johnson, W Somerfield, SR Johnson - Orphanet Journal of Rare …, 2024 - Springer
90 天前 - … 55% required treatment with either sirolimus or Everolimus for LAM or angiomyolipoma
respectively. For those treated with an mTOR inhibitor, mean FEV 1 fell by 3 ml/year and …
respectively. For those treated with an mTOR inhibitor, mean FEV 1 fell by 3 ml/year and …
Genetic diffuse cystic lung disease in adults
R Diesler, K Ahmad, L Chalabreysse… - Revue des Maladies …, 2023 - europepmc.org
228 天前 - … Lymphangioleiomyomatosis (LAM) is a disease occurring almost exclusively in
women, sporadically or in association with tuberous sclerosis … target of rapamycin (mTOR) …
women, sporadically or in association with tuberous sclerosis … target of rapamycin (mTOR) …